Annual Accounts Payable
$821.00 K
+$113.00 K+15.96%
December 31, 2023
Summary
- As of February 12, 2025, NRBO annual accounts payable is $821.00 thousand, with the most recent change of +$113.00 thousand (+15.96%) on December 31, 2023.
- During the last 3 years, NRBO annual accounts payable has fallen by -$1.75 million (-68.12%).
- NRBO annual accounts payable is now -79.60% below its all-time high of $4.03 million, reached on December 31, 2017.
Performance
NRBO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.02 M
-$1.61 M-61.36%
September 30, 2024
Summary
- As of February 12, 2025, NRBO quarterly accounts payable is $1.02 million, with the most recent change of -$1.61 million (-61.36%) on September 30, 2024.
- Over the past year, NRBO quarterly accounts payable has increased by +$196.00 thousand (+23.87%).
- NRBO quarterly accounts payable is now -76.52% below its all-time high of $4.33 million, reached on September 30, 2017.
Performance
NRBO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NRBO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.0% | +23.9% |
| 3 y3 years | -68.1% | +6.7% |
| 5 y5 years | +382.9% | -62.0% |
NRBO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.1% | +16.0% | -61.4% | +53.2% |
| 5 y | 5-year | -68.1% | +28.7% | -61.4% | +193.1% |
| alltime | all time | -79.6% | +3809.5% | -76.5% | +498.2% |
NeuroBo Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.02 M(-61.4%) |
| Jun 2024 | - | $2.63 M(+26.6%) |
| Mar 2024 | - | $2.08 M(+153.2%) |
| Dec 2023 | $821.00 K(+16.0%) | $821.00 K(-58.6%) |
| Sep 2023 | - | $1.98 M(+104.9%) |
| Jun 2023 | - | $967.00 K(-13.6%) |
| Mar 2023 | - | $1.12 M(+58.1%) |
| Dec 2022 | $708.00 K(-14.7%) | $708.00 K(-34.1%) |
| Sep 2022 | - | $1.07 M(+61.9%) |
| Jun 2022 | - | $664.00 K(-14.4%) |
| Mar 2022 | - | $776.00 K(-6.5%) |
| Dec 2021 | $830.00 K(-67.8%) | $830.00 K(-12.9%) |
| Sep 2021 | - | $953.00 K(+174.6%) |
| Jun 2021 | - | $347.00 K(-25.9%) |
| Mar 2021 | - | $468.00 K(-81.8%) |
| Dec 2020 | $2.58 M | $2.58 M(+133.9%) |
| Sep 2020 | - | $1.10 M(-34.6%) |
| Jun 2020 | - | $1.68 M(+32.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $1.27 M(+99.5%) |
| Dec 2019 | $638.00 K(+275.3%) | $638.00 K(-76.2%) |
| Sep 2019 | - | $2.68 M(+60.5%) |
| Jun 2019 | - | $1.67 M(+35.2%) |
| Mar 2019 | - | $1.23 M(+625.9%) |
| Dec 2018 | $170.00 K(-95.8%) | $170.00 K(-92.8%) |
| Sep 2018 | - | $2.35 M(-8.5%) |
| Jun 2018 | - | $2.57 M(-9.8%) |
| Mar 2018 | - | $2.85 M(-29.2%) |
| Dec 2017 | $4.03 M(+100.4%) | $4.03 M(-7.1%) |
| Sep 2017 | - | $4.33 M(+25.1%) |
| Jun 2017 | - | $3.46 M(-2.2%) |
| Mar 2017 | - | $3.54 M(+76.3%) |
| Dec 2016 | $2.01 M(+278.2%) | $2.01 M(+59.7%) |
| Sep 2016 | - | $1.26 M(+95.8%) |
| Jun 2016 | - | $642.00 K(+186.6%) |
| Mar 2016 | - | $224.00 K(-57.8%) |
| Dec 2015 | $531.00 K(+2428.6%) | $531.00 K |
| Dec 2014 | $21.00 K | - |
FAQ
- What is NeuroBo Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals annual accounts payable year-on-year change?
- What is NeuroBo Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly accounts payable year-on-year change?
What is NeuroBo Pharmaceuticals annual accounts payable?
The current annual accounts payable of NRBO is $821.00 K
What is the all time high annual accounts payable for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual accounts payable is $4.03 M
What is NeuroBo Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, NRBO annual accounts payable has changed by +$113.00 K (+15.96%)
What is NeuroBo Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of NRBO is $1.02 M
What is the all time high quarterly accounts payable for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly accounts payable is $4.33 M
What is NeuroBo Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, NRBO quarterly accounts payable has changed by +$196.00 K (+23.87%)